GMP MANUFACTURING LTD — Rivaroxaban Importer Profile
Pharmaceutical Importer · #10 buyer for Rivaroxaban · $331.3K import value · 12 shipments · UNITED KINGDOM · DGFT Verified
GMP MANUFACTURING LTD is the #10 importer of Rivaroxaban from India with $331.3K in import value and 12 verified shipments. GMP MANUFACTURING LTD holds a 1.1% market share in Rivaroxaban imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 12 formulations shipped to 1 country.
GMP MANUFACTURING LTD — Rivaroxaban Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Rivaroxaban to GMP MANUFACTURING LTD?
Verified from 12 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| UNISON PHARMACEUTICALS PRIVATE LIMITED | $331.3K | 12 | 100.0% |
GMP MANUFACTURING LTD sources Rivaroxaban from 1 verified Indian supplier based on 12 customs records. The primary supplier is UNISON PHARMACEUTICALS PRIVATE LIMITED accounting for 100.0% of imports.
How Does GMP MANUFACTURING LTD Compare to Nearest Rivaroxaban Importers?
Buyers ranked immediately above and below #10 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | TORRENT DO BRASIL LTDA | BRAZIL | $688.7K | 20 | $34.4K |
| 12 | MYLAN IRELAND | NETHERLANDS | $653.5K | 33 | $19.8K |
| 10 | GMP MANUFACTURING LTD ★ | UNITED KINGDOM | $600.0K | 12 | $50.0K |
| 15 | APOTEX INC, | CANADA | $506.4K | 17 | $29.8K |
| 16 | APOTEX INC,-4100 WESTON ROAD | CANADA | $499.7K | 10 | $50.0K |
GMP MANUFACTURING LTD ranks #10 among 497 Rivaroxaban importers from India. Average shipment value of $50.0K compared to the market average of $33.2K. The closest competitors by value are TORRENT DO BRASIL LTDA and MYLAN IRELAND.
Where Does GMP MANUFACTURING LTD Import Rivaroxaban To?
Destination countries from 12 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $331.3K | 12 | 100.0% |
GMP MANUFACTURING LTD imports Rivaroxaban to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $331.3K.
What Rivaroxaban Formulations Does GMP MANUFACTURING LTD Import?
| Formulation | Value | Shipments |
|---|---|---|
| RIVAROXABAN 10 MG FC TABLETS(3X10T)BL (RIVAROXABAN)) B.NO 2431219 & 2431220 (1 NOS=1 PACKS) AS PER INV | $50.0K | 1 |
| RIVAROXABAN 15 MG FC TABLETS(2X14T)BL (RIVAROXABAN) B.NO 2431206, 2431221 & 2431222 (1 NOS=1 PACKS) AS PER INV | $50.0K | 1 |
| RIVAROXABAN 20 MG FC TABLETS(2X14T)BL (RIVAROXABAN)B.NO 2431266,2431267,2431268(1 NOS=1 PACKS) AS PER INV | $50.0K | 1 |
| RIVAROXABAN 20MG FC TABLETS RIVAROXABAN 2X14 T 1 NOS 1 PACK B NO 2530384 2530385 2530386 2530387 MFG DT 03 | $50.0K | 1 |
| RIVAROXABAN 15MG FC TABLETS RIVAROXABAN 2X14 T 1 NOS 1 PACK B NO 2530383MFG DT 03 25 EXP DT 02 28 | $41.0K | 1 |
| RIVAROXABAN 10 MG FC TABLETS(3X10T)BL (RIVAROXABAN) B.NO 2431205 (1 NOS=1 PACKS)AS PER INV | $32.4K | 1 |
| RIVAROXABAN 15 MG FC TABLETS(2X14T)BL (RIVAROXABAN) (AS PER INVOICE )(PACK SIZE:2X14) B.NO.2430570 (1NOS=1 PACKS) | $15.2K | 1 |
| RIVAROXABAN 2.5 MG FC TABLETS(4X14T)BL (RIVAROXABAN) B.NO 2431173 - 2431175 (1 NOS=1 PACKS) AS PER INV | $10.8K | 1 |
| RIVAROXABAN 2.5 MG FC TABLETS(4X14T)BL (RIVAROXABAN) B.NO 2431182 - 2431184 (1 NOS=1 PACKS) AS PER INV | $10.7K | 1 |
| RIVAROXABAN 2.5 MG FC TABLETS(4X14T)BL (RIVAROXABAN) (AS PER INVOICE )(PACK SIZE: 4X4) B.NO.2430567,2430568 (1NOS=1 PACK | $8.4K | 1 |
GMP MANUFACTURING LTD imports 12 distinct Rivaroxaban formulations from India. The top formulation is RIVAROXABAN 10 MG FC TABLETS(3X10T)BL (RIVAROXABAN)) B.NO 24 with 1 shipments worth $50.0K.
Regulatory Requirements: Importing Rivaroxaban into United Kingdom
What GMP MANUFACTURING LTD and other importers must comply with to import Rivaroxaban from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Rivaroxaban
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Rivaroxaban from India and How Much Does GMP MANUFACTURING LTD Import?
India exported $16.5M worth of Rivaroxaban through 5,361 shipments from 221 suppliers to 115 countries, serving 497 buyers globally. GMP MANUFACTURING LTD imports $331.3K of this total, accounting for 1.1% of India's Rivaroxaban exports with 12 shipments from UNITED KINGDOM. This is verified from 12 customs shipment records covering 12 distinct formulations.
What Is the Average Order Value for GMP MANUFACTURING LTD's Rivaroxaban Imports?
GMP MANUFACTURING LTD's average Rivaroxaban order value is $27.6K per consignment, based on 12 shipments totaling $331.3K. GMP MANUFACTURING LTD is based in UNITED KINGDOM and ranks #10 among all Rivaroxaban importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Rivaroxaban to GMP MANUFACTURING LTD?
GMP MANUFACTURING LTD sources Rivaroxaban from 1 verified Indian supplier: UNISON PHARMACEUTICALS PRIVATE LIMITED ($331.3K, 100.0%). This is based on 12 customs records.
How Does GMP MANUFACTURING LTD Compare to Other Rivaroxaban Importers?
GMP MANUFACTURING LTD ranks #10 among 497 Rivaroxaban importers from India with a 1.1% market share. The top 3 importers are MYLAN IRELAND C/O ALLOGA RDC, ($4.2M), PHARMADOX HEALTHCARE LTD ($3.9M), APOTEX INC ($1.3M). GMP MANUFACTURING LTD processed 12 shipments from UNITED KINGDOM.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rivaroxaban — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rivaroxaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: GMP MANUFACTURING LTD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as GMP MANUFACTURING LTD's capped import value divided by total capped export value for Rivaroxaban across all Indian exporters.
- 5.Verified Records: This page is backed by 12 individual customs records matching GMP MANUFACTURING LTD importing Rivaroxaban, covering 12 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 497+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rivaroxaban Import Data for GMP MANUFACTURING LTD
Access order-level details, pricing data, supplier connections, and competitive analysis for GMP MANUFACTURING LTD's Rivaroxaban imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
GMP MANUFACTURING LTD
Company Profile
Multiple products · $0 total trade · Multiple categories
GMP MANUFACTURING LTD × Rivaroxaban
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for GMP MANUFACTURING LTD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rivaroxaban. For current order-level data, contact TransData Nexus.